healthandpharma5h
New Oral SERD Imlunestrant Shows Promising Results Alone and with Verzenio in ER+, HER2- Breast Cancer
Imlunestrant, an oral SERD, significantly prolonged progression-free survival in patients with advanced ER+, HER2- breast ...